| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |